{"mainPropery":{"diseaseId":547,"diseaseName":"Adenosine monophosphate deaminase 1 deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/547/adenosine-monophosphate-deaminase-1-deficiency","synonyms":["AMP deaminase 1 deficiency","Myoadenylate deaminase deficiency","AMPD1 deficiency","Myopathy due to myoadenylate deaminase deficiency","MMDD","Adenosine monophosphate deaminase deficiency","AMP deaminase deficiency"],"synonyms-with-source":[{"name":"AMP deaminase 1 deficiency"},{"name":"Myoadenylate deaminase deficiency"},{"name":"AMPD1 deficiency","source":"OMIM"},{"name":"Myopathy due to myoadenylate deaminase deficiency","source":"OMIM"},{"name":"MMDD","source":"OMIM"},{"name":"Adenosine monophosphate deaminase deficiency","source":"OrphaData.Org"},{"name":"AMP deaminase deficiency","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"615511"},{"identifierType":"ORPHANET","identifierId":"45"},{"identifierType":"UMLS","identifierId":"C0268123"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/615511' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed?term=%28Adenosine%5BTitle%5D%20AND%20monophosphate%5BTitle%5D%20AND%20deaminase%5BTitle%5D%20AND%201%5BTitle%5D%20AND%20deficiency%5BTitle%5D%29%20OR%20%28AMP%5BTitle%5D%20AND%20deaminase%5BTitle%5D%20AND%201%5BTitle%5D%20AND%20deficiency%5BTitle%5D%29%20OR%20%28Myoadenylate%5BTitle%5D%20AND%20deaminase%5BTitle%5D%20AND%20deficiency%5BTitle%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Adenosine monophosphate deaminase 1 deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=adenosinemonophosphatedeaminasedeficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Adenosine monophosphate deaminase 1 deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"Orphanet is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n<a href='http://www.orpha.net/data/patho/GB/uk-AMPD.pdf' target='_blank'>Orphanet</a><br /><a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=45' target='_blank'>Orphanet</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/pediatrics/inherited_disorders_of_metabolism/purine_and_pyrimidine_metabolism_disorders.html?qt=&sc=&alt=' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Adenosine monophosphate deaminase 1 deficiency.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:615511' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1933,"questionText":"What is&nbsp;adenosine monophosphate deaminase 1 deficiency?","answerText":"<strong>Adenosine monophosphate deaminase 1 (AMPD1) deficiency</strong>&nbsp;is an inherited condition that can affect the muscles used for movement (skeletal muscles). Many people with AMPD1 deficiency do not have symptoms. People who do have symptoms typically have muscle pain (myalgia), cramping, and weakness after exercise, and often get tired faster than others. Some affected people appear to have more severe symptoms. AMPD1 deficiency is caused by changes (mutations) in the&nbsp;<a class=\"link-dapple\" title=\"A M P D 1\" href=\"http://ghr.nlm.nih.gov/gene=ampd1\" target=\"_blank\"><em>AMPD1</em></a>&nbsp;gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[1186]<br />\r\n<br />\r\nOther types of AMPD deficiency include the&nbsp;acquired type (due to a muscle or joint condition), and the coincidental inherited type (due to both mutations in the <em>AMPD1</em> gene <em>and</em> a separate muscle or joint disorder).[1186]","dateModified":"2016-08-23T00:00:00"},"basicQuestions":[{"questionId":1934,"questionText":"What are the signs and symptoms of adenosine monophosphate deaminase 1 deficiency?","answerText":"In many people, adenosine monophosphate deaminase 1 (AMPD1) deficiency does not cause any symptoms. The reasons for this are unclear. People who do have symptoms typically have muscle pain (myalgia) or weakness after exercise or prolonged physical activity. They often get tired more quickly and stay tired longer than others. Some people have more severe symptoms, but it is unclear whether these symptoms are due solely to AMPD1 deficiency, or additional factors.[1186]","dateModified":"2015-03-04T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1186,"authors":"","articleTitle":"Adenosine monophosphate deaminase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"July 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=adenosinemonophosphatedeaminasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1935,"questionText":"What causes adenosine monophosphate deaminase 1&nbsp;deficiency?","answerText":"Adenosine monophosphate deaminase 1 (AMPD1) deficiency is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the&nbsp;<a class=\"link-dapple\" title=\"A M P D 1\" href=\"http://ghr.nlm.nih.gov/gene=ampd1\" target=\"_blank\"><span><em>AMPD1</em></span></a> gene. This gene gives the body&nbsp;instructions to make an enzyme called AMP deaminase, which plays a role in producing energy in skeletal muscle cells. Mutations in the <em>AMPD1</em> gene disrupt the function of AMP deaminase, which impairs the ability of muscle cells to make energy. This lack of energy can lead to the muscle problems associated with AMPD1 deficiency.[1186]<br />\r\n<br />\r\nOther types of AMPD deficiency are known as the acquired type (due to a different muscle or joint condition), and the coincidental inherited type (due to both mutations in the <em>AMPD1</em> gene <em>and</em> a separate muscle or joint disorder).[1186]","dateModified":"2015-03-04T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1186,"authors":"","articleTitle":"Adenosine monophosphate deaminase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"July 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=adenosinemonophosphatedeaminasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1936,"questionText":"How is adenosine monophosphate deaminase 1 deficiency inherited?&nbsp;","answerText":"This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner, which means that both copies of the responsible gene in each cell must have changes (mutations) for a person to be affected. The parents of a person with an autosomal recessive condition each carry one copy of the mutated gene and are referred to as carriers. Carriers are not affected and typically do not have signs and symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) chance to be affected, a 50% (1 in 2) chance to be a carrier like each parent, and a 25% chance to be unaffected <em>and</em> not be a carrier.<br />\r\n<br />\r\nThere are many people who have mutations in both copies of the gene responsible for AMPD1 deficiency, but do not have any signs or symptoms (are unaffected). &nbsp;The reasons for this are unclear.<span style=\"font-size: 14.3999996185303px;\">[1186]<br />\r\n</span>","dateModified":"2015-03-04T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1186,"authors":"","articleTitle":"Adenosine monophosphate deaminase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"July 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=adenosinemonophosphatedeaminasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1937,"questionText":"How might adenosine monophosphate deaminase 1 (AMP1) deficiency be treated?","answerText":"Although there is no cure for AMP1 deficiency, there may be ways to manage symptoms. One possibility  is the use of a sugar called D-ribose.[1188][1189][1190] This sugar is easily absorbed in digestive system and rapidly cleared by metabolic pathways. It may provide an additional source of energy for muscle' however, the helpful effects of D-ribose are short-term.[1189][1190]","dateModified":"2016-09-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1188,"authors":"Gross M","articleTitle":"","bookWebsiteJournalTitle":"Orphanet","date":"September 2001","url":"http://www.orpha.net/data/patho/GB/uk-AMPD.pdf","dateAccessed":"2009-05-12T00:00:00"},{"referenceId":1189,"authors":"Sabina RL, Holmes EW","articleTitle":"Myoadenylate Deaminase Deficiency","bookWebsiteJournalTitle":"The Molecular and Metabolic Bases of Genetic Diseases, 8th edition","date":"2001","authors2":"","placeOfPublication":"New York, NY","publisher":"McGraw Hill"},{"referenceId":1190,"authors":"Harris JC","articleTitle":"Chapter 89 - Disorders of Purine and Pyrimidine Metabolism","bookWebsiteJournalTitle":"Nelson Textbook of Pediatrics, 18th edition","date":"2007","authors2":"","placeOfPublication":"","publisher":"Saunders"}]},{"questionId":8391,"questionText":"What is the long-term outlook for people with adenosine monophosphate deaminase 1 deficiency?","answerText":"People with this condition may first develop symptoms during childhood, adolescence, or as young or older adults. Many people do not have any symptoms. Those with symptoms typically have only rapid fatigue, cramps or muscle pain (myalgia) after exercising.[8455] &nbsp;In some cases, symptoms may progress over the first few years, but then the condition usually stabilizes (does not get worse).[8455] In many people, it is not progressive at all.[8456]&nbsp;<span style=\"font-size: 14.3999996185303px;\">There are no known consistent complications of the condition.[8456]&nbsp;</span>There is no evidence of muscular dystrophy or muscular wasting in affected people, and it does not affect smooth muscle or other organs (only skeletal muscle). Life expectancy is not shortened.[8455]","dateModified":"2015-03-04T12:33:00","resourceClassificationName":"Prognosis","references":[{"referenceId":8455,"authors":"Manfred Gross","articleTitle":"Adenosine monophosphate deaminase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2007","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=45","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8456,"authors":"Sabina RL","articleTitle":"Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation","bookWebsiteJournalTitle":"Neurol Clin","date":"February, 2000","volume":"18(1)","pages":"185-194","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":50361,"abbreviatedInquiry":"Does this disease affect your life span? Will it affect how you live your daily life?","caseQuestions":[{"questionId":8391,"questionText":"What is the long-term outlook for people with adenosine monophosphate deaminase 1 deficiency?","answerText":"People with this condition may first develop symptoms during childhood, adolescence, or as young or older adults. Many people do not have any symptoms. Those with symptoms typically have only rapid fatigue, cramps or muscle pain (myalgia) after exercising.[8455] &nbsp;In some cases, symptoms may progress over the first few years, but then the condition usually stabilizes (does not get worse).[8455] In many people, it is not progressive at all.[8456]&nbsp;<span style=\"font-size: 14.3999996185303px;\">There are no known consistent complications of the condition.[8456]&nbsp;</span>There is no evidence of muscular dystrophy or muscular wasting in affected people, and it does not affect smooth muscle or other organs (only skeletal muscle). Life expectancy is not shortened.[8455]","dateModified":"2015-03-04T12:33:00","resourceClassificationName":"Prognosis","references":[{"referenceId":8455,"authors":"Manfred Gross","articleTitle":"Adenosine monophosphate deaminase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2007","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=45","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8456,"authors":"Sabina RL","articleTitle":"Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation","bookWebsiteJournalTitle":"Neurol Clin","date":"February, 2000","volume":"18(1)","pages":"185-194","url":"","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":50222,"abbreviatedInquiry":"My daughter is pregnant and has adenosine monophosphate deaminase deficiency and her symptoms can be very severe. How would that affect her giving birth? ","caseQuestions":[{"questionId":8312,"questionText":"Is adenosine monophosphate (AMP) deaminase deficiency associated with pregnancy complications?","answerText":"There is very limited information on AMP deaminase deficiency and pregnancy. One case report of a pregnant woman with AMP deaminase deficiency described the pregnancy as normal. In this case there was a spontaneous vaginal delivery without\r\ncomplication. Uterine contractions were normal (uterine contractions involve smooth muscle and AMP deaminase deficiency does not affect smooth muscle). In this case, the pregnancy did\r\nnot affect the course of AMP deaminase deficiency (i.e., it didn't worsen symptoms).[8312] <br />\r\n<br />\r\nSigns and symptoms of AMP deaminase deficiency can vary. We encourage your loved one to discuss any questions regarding her pregnancy and AMP deaminase deficiency with her healthcare provider.","dateModified":"2015-02-17T15:57:00","references":[{"referenceId":8328,"authors":"Bellver J et al.,","articleTitle":"Myoadenylate deaminase deficiency myopathy in pregnancy","bookWebsiteJournalTitle":"Arch Gynecol Obstet","date":"1997","volume":"259(3)","pages":"157-9","url":"http://www.ncbi.nlm.nih.gov/pubmed/9187470","dateAccessed":"2015-02-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3465,"phenoTypeName":"Exercise-induced muscle fatigue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5304,"phenoTypeName":"Exercise-induced myalgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5264,"phenoTypeName":"Limb muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14503,"phenoTypeName":"Rhabdomyolysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5317,"phenoTypeName":"Increased muscle fatiguability","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Adenosine_monophosphate_deaminase_1_deficiency"}